Michael Camilleri
Michael Camilleri
Professor of Medicine, Pharmacology and Physiology, Mayo Clinic
Verified email at
Cited by
Cited by
Functional gastroduodenal disorders
J Tack, NJ Talley, M Camilleri, G Holtmann, P Hu, JR Malagelada, ...
Gastroenterology 130 (5), 1466-1479, 2006
AGA technical review on irritable bowel syndrome
DA Drossman, M Camilleri, EA Mayer, WE Whitehead
Gastroenterology 123 (6), 2108-2131, 2002
Chronic constipation
A Lembo, M Camilleri
New England Journal of Medicine 349 (14), 1360-1368, 2003
Clinical guideline: management of gastroparesis
M Camilleri, HP Parkman, MA Shafi, TL Abell, L Gerson
The American journal of gastroenterology 108 (1), 18, 2013
Irritable bowel syndrome: a technical review for practice guideline development
DA Drossman, WE Whitehead, M Camilleri
Gastroenterology 112 (6), 2120-2137, 1997
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
TL Abell, M Camilleri, K Donohoe, WL Hasler, HC Lin, AH Maurer, ...
Journal of nuclear medicine technology 36 (1), 44-54, 2008
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
M Camilleri, AR Northcutt, S Kong, GE Dukes, D McSorley, AW Mangel
The Lancet 355 (9209), 1035-1040, 2000
Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis
R Khera, MH Murad, AK Chandar, PS Dulai, Z Wang, LJ Prokop, ...
Jama 315 (22), 2424-2434, 2016
A placebo-controlled trial of prucalopride for severe chronic constipation
M Camilleri, R Kerstens, A Rykx, L Vandeplassche
New England Journal of Medicine 358 (22), 2344-2354, 2008
A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome
HJ Kim, M Camilleri, S McKinzie, MB Lempke, DD Burton, GM Thomforde, ...
Alimentary pharmacology & therapeutics 17 (7), 895-904, 2003
Serotonin: a mediator of the brain-gut connection
DY Kim, M Camilleri
The American journal of gastroenterology 95 (10), 2698, 2000
Intestinal barrier function in health and gastrointestinal disease
M Camilleri, K Madsen, R Spiller, BG Van Meerveld, GN Verne
Neurogastroenterology & Motility 24 (6), 503-512, 2012
Management of the irritable bowel syndrome
M Camilleri
Gastroenterology 120 (3), 652-668, 2001
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function
MI Vazquez–Roque, M Camilleri, T Smyrk, JA Murray, E Marietta, J O'Neill, ...
Gastroenterology 144 (5), 903-911. e3, 2013
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
CM Prather, M Camilleri, AR Zinsmeister, S McKinzie, G Thomforde
Gastroenterology 118 (3), 463-468, 2000
A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating
HJ Kim, MI Vazquez Roque, M Camilleri, D Stephens, DD Burton, ...
Neurogastroenterology & Motility 17 (5), 687-696, 2005
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
SV Kane, WJ Sandborn, PA Rufo, A Zholudev, J Boone, D Lyerly, ...
The American journal of gastroenterology 98 (6), 1309-1314, 2003
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.
M Camilleri, EA Mayer, DA Drossman, A Heath, GE Dukes, D McSorley, ...
Alimentary pharmacology & therapeutics 13 (9), 1149-1159, 1999
Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study
M Camilleri, D Dubois, B Coulie, M Jones, PJ Kahrilas, AM Rentz, ...
Clinical Gastroenterology and Hepatology 3 (6), 543-552, 2005
Diabetic gastroparesis
M Camilleri
New England Journal of Medicine 356 (8), 820-829, 2007
The system can't perform the operation now. Try again later.
Articles 1–20